Skip to Content
Modyfi Icon

Tempus (Pharacogenetic Testing) explained

Tempus (Pharacogenetic Testing) evaluates genetic variants that may influence how you metabolize or respond to certain psychiatric medications.

Some panels have FDA‑cleared components; overall offering typically LDT under CLIA

Tempus (Pharacogenetic Testing) helps treat

• Pharmacogenetic guidance for medication selection
• Metabolism (CYP450) and transport variants
• Side‑effect risk discussions


additional medications

• Related clinical evaluation and history
• Repeat testing to confirm abnormal results
• Additional targeted labs as recommended

medication risks

• Genetic privacy and potential insurance/employment implications
• Limited clinical actionability for some markers

side effects

• Emotional impact of unexpected findings

WE'LL GET YOU THE RIGHT TOOLS

take the first step.

Get Started
Request Refill

FAQs

Q: Does it replace clinical judgment?
A: No—results supplement, not replace, clinician decision‑making.

Q: Guaranteed to improve outcomes?
A: No—evidence varies by drug/gene; utility depends on case.

Q: Privacy/insurance?
A: Genetic data has implications; review policies and GINA protections.

Q: Sample?
A: Usually cheek swab/saliva.

Q: Turnaround?
A: Typically 1–3 weeks.

helpful resources